Erich Fischer

Assistant Professor of BCMP at Harvard Medical School and Dana-Farber Cancer Institute. He co-directs the DFCI Center for Protein Degradation, SAB member of C4 Therapeutics. His research focuses on understanding the complex mechanisms that underlie the function and regulation of multi-component ubiquitin ligases and their role in disease. Dr. Fischer has been recognized for his pioneering work on the structure of cereblon and the mechanism of action of thalidomide.